+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

From
From
From
Digital Marketing Trends in Severe Asthma - Product Thumbnail Image

Digital Marketing Trends in Severe Asthma

  • Report
  • August 2022
  • 35 Pages
  • Global
From
From
Digital Marketing Trends in Breast Cancer - Product Thumbnail Image

Digital Marketing Trends in Breast Cancer

  • Report
  • November 2022
  • 34 Pages
  • Global
From
From
From
Occupational Health Global Market Report 2024 - Product Thumbnail Image

Occupational Health Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Murine Double Minute 2 (MDM2) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Murine Double Minute 2 (MDM2) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
TRAIL Receptor 1 & Receptor 2 Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

TRAIL Receptor 1 & Receptor 2 Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
B-Cell Activating Factor (BAFF) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

B-Cell Activating Factor (BAFF) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Tie-2 Receptor Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Tie-2 Receptor Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Loading Indicator